如何避免二次中風?-黃秉康腦神經外科專科醫生@FindDoc.com

Поділитися
Вставка
  • Опубліковано 2 лис 2024
  • 如何避免二次中風?-黃秉康腦神經外科專科醫生@FindDoc.com
    FindDoc Facebook : / finddoc
    FindDoc WeChat : 快徳健康香港 FindDoc
    FindDoc Instagram:@finddochk
    (一)中風有什麼後遺症? 00:06
    (二)認如何護理中風後遺症? 00:25
    (三)阿如何避免二次中風及降低死亡風險? 01:10
    (四)有甚麼藥物可降低膽固醇,避免二次中風? 01:48
    (本短片作健康教育之用,並不可取代任何醫療診斷或治療。治療成效因人而異,如有疑問,請向專業醫療人士諮詢。)
    參考資料:
    1. Hospital Authority (2021). Smart Patient-Stroke. Retrieved 30 March 2021, from www21.ha.org.h...
    2. American Heart Association. (2015). Complications After Stroke [Brochure]. Author. Retrieved March 30, 2021, from www.stroke.org...
    3. Rothwell P. M. (2007). Making the most of secondary prevention. Stroke, 38(6), 1726. doi.org/10.116...
    4. University of Michigan Health System. (2006). Two Strokes And You're Out? Study Looks At Death Risk And Ethnic Differences In Stroke Survivors. Retrieved June 8, 2021 from www.sciencedaily.com/releases/2006/08/060822171545.html
    5. Hackam, D. G., & Spence, J. D. (2007). Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke, 38(6), 1881-1885.
    6. Hospital Authority New Territories East Cluster (2005). 飲食與預防中風. Retrieved 30 March 2021, from www3.ha.org.hk...
    7. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2019; 41(1): 111-88.
    8. Madhu, K., Raju, S. B., & Varghese, K. (2013). Management of statin intolerance. Indian Journal of Endocrinology and Metabolism, 17(6), 977-982. doi:10.4103/2230-8210.122602
    9. Chaudhary, R., Garg, J., Shah, N., & Sumner, A. (2017). Pcsk9 inhibitors: A new era of lipid lowering therapy. World Journal of Cardiology, 9(2), 76. doi:10.4330/wjc.v9.i2.7
    10. Fala L. (2016). Repatha (Evolocumab): Second PCSK9 Inhibitor Approved by the FDA for Patients with Familial Hypercholesterolemia. American health & drug benefits, 9(Spec Feature), 136-139.
    資料來源:www.FindDoc.com
    查詢醫生資訊:www.finddoc.com/

КОМЕНТАРІ •